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Introduction
Treating burn wounds represents one of the most recent 
crucial issues. Considering the human body mechanism 
in efficient tissue repair and in preventing infections, 
during early hours after an injury, it is observed that about 
70% of the mortality rate occurs due to resistant infection 
during the subsequent days after the injury.1
Pseudomonas aeruginosa is an opportunistic gram-
negative bacterium belonging to the gamma-
proteobacteria order, which is one of the main causes of 
infection and biofilm formation in immunocompromized 
and cystic fibrosis patients, in patients with bed wounds, 
and also in infections due to medical instruments such 
as catheters.2 Known to be crucial in burn wounds, this 
bacterium possesses high instinct resistance toward 
several antibiotics and can achieve acquired resistance 
shortly after the antibiotic therapy. Besides, it is essential 
in the formation of drug-resistant biofilm. According 
to Centers for Disease Control and Prevention (CDC) 
reports, P. aeruginosa is placed among the top ten resistant 
bacteria worldwide. Its high resistance and pathogenicity 
are essentially due to the function of quorum sensing 
(QS) and efflux pumps.2
Quorum Sensing
Communication between similar or different species 
occurs via various chemical signals produced and secreted 
by the bacteria. These signals can be population dependent 
(QS) or can be secreted during several proliferation stages 
(e.g., indole, which is secreted in the stationary phase by 
Escherichia coli). The main difference between releasing 
signals in different proliferation stages and QS is that the 
QS signal is controlled by the increase in the population 
density.3 Initially, in the 1970s, it was found that in a 
Gram-negative and marine bacterium Vibrio fischeri, 
light production was controlled by population density. In 
1994 it was proven that a threshold density is necessary for 
intracellular recognition of the autoinducer (AI) signals. 
 Review Article
doi 10.15171/jlms.2018.30
The Effect of Quorum-Sensing and Efflux Pumps 
Interactions in Pseudomonas aeruginosa Against 
Photooxidative Stress
Parizad Rezaie1†, Maryam Pourhajibagher2†, Nasim Chiniforush3†, Nava Hosseini1, Abbas Bahador4*
1Department of Microbiology, Faculty of Biology, College of Science, University of Tehran, Tehran, Iran
2Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
3Laser Research Center of Dentistry (LRCD), Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran
4Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Resistant infections essentially cause mortality in a burn unit. Several bacteria contribute to 
burn infections; among these, Pseudomonas aeruginosa majorly contributes to these infections 
revealing significant drug resistance. Similar to other bacteria, P. aeruginosa reveals various 
mechanisms to attain highest pathogenicity and resistance; among these, efflux pumps and 
quorum sensing are crucial. Quorum sensing enables effective communication between 
bacteria and synchronizes their gene expression resulting in optimum effect of the secreted 
proteins; alternatively, efflux pumps increase the bacterial resistance by pumping out the 
antimicrobial factors as well as the QS signals and precursors. Of recent, increasing episodes 
of drug resistance led to new findings and approaches for killing pathogenic bacteria without 
inducing the drug-resistant species. Photodynamic therapy (PDT), considered as an adjuvant 
and innovative method for conventional antibiotic therapy, is a photochemical reaction that 
includes visible light, oxygen, and a photosensitizer (PS). In this therapy, after exposure to visible 
light, the PS generates reactive oxygen species (ROS) that are bacteriostatic or bactericidal. 
Furthermore, this oxidative stress can disrupt the coordination of gene expression and alter the 
bacterial behavior. Considering the fact that the adaption and several gene expression patterns 
of microorganisms within the biofilm make them notably resistant to the recent antimicrobial 
treatments, this study aimed to emphasize the relationship between the efflux pump and QS 
under oxidative stress and their role in P. aeruginosa’s reaction to PDT.
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The name quorum was coined for threshold density and 
quorum sensing for this respective phenomenon. After 
V. fischeri, QS was studied in several gram-positive 
and gram-negative bacteria, and it was discovered that 
population density-dependent phenotype changes help 
bacterial growth during continuous environmental 
changes.4-7
The QS system of V. fischeri is considered as a model 
system for several Gram-negative bacteria. This system 
comprises 2 regulatory proteins, LuxR and LuxI. LuxI 
produces autoinducer signal and LuxR recognizes the 
signal.
LuxR type proteins have 2 separate domains; the one 
present in the N-terminal binds to the ligands (LBD), 
whereas the other present in the C-terminal binds to 
DNA (DBD). In the absence of AI, the majority of the 
LuxR protein domains fold inappropriately and degrade 
instantly (if they do not bind to their specific ligand); 
however, after binding to the ligand, AI and LuxR complex 
stabilizes. Ligand binding results in a conformational 
change, which allows DBD to bind to the promoter 
and initiates gene transcription. In all Lux homologs, 
AI reveals similar homoserine lactone structure with 
different length alkyl chains.8-11 Two types of Lux protein 
families have been identified in P. aeruginosa, LasI/LasR 
and RhlI/RhlR, which are able to recognize (OdDHL) 
3oxoC12HSL and C4HSL as AI. These systems control the 
expression of several genes involved in the pathogenicity 
and biofilm formation, such as exotoxin A, rhamnolipid, 
pyocyanin, alkaline phosphatase, and elastase, and are 
crucial in regulating more than 300 genes. In addition, 
PQS and IQS systems were identified as acyl homoserine 
lactone (AHL) independent QS systems in P. aeruginosa. 
Each of the 4 systems is responsible for inter-hierarchy 
regulation. LasR is on the top, which regulates several 
genes including lasI/R, rhl I/R, pqs R, and pqsABCDH 
(genes in PQS system) through AHL. RhlI reveals similar 
effect as LasR and regulates the expression of las and pqs 
and along with self-regulation, after binding to C4HSL. 
PQS system regulates its own genes and also feedbacks 
the active Rhl which connects the Rhl, Las, and PQS 
signaling systems.
Despite RhlR being the key component of QS in P. 
aeruginosa after binding of C4HSL to RhlR, another AI 
should also be involved in pathogenicity. In wild species, 
the other system is Las; however, in clinical species, Las 
mutant has been found. Phosphate starvation protein 
Pho B compensates the Las activities by activating IQS. 
IQS leads to pqs expression, thus, preparing AI for rhl 
expression. These system and interactions make these 
bacteria immune to the Las mutation.12-16
Efflux Pumps
Efflux pumps are transporter proteins which are located 
in cytoplasmic membrane and exert compounds. They 
use ATP (active transport) or can act as secondary active 
transporters or antiports and use proton motif force and/
or sodium motif force as an energy source.17
All the bacterial efflux pumps presently known belong 
to these 6 major families, the last group being newly 
described:
1- ATP-binding cassette (ABC)
2- Major facilitator superfamily (MFS)
3- Division resistance nodulation cell division (RND)
4- Small multidrug resistance (SMR)
5- Multidrug and toxic compound extrusion (MATE)
6- Proteobacterial antimicrobial compound efflux 
(PACE)17,18
The Role of Efflux Pumps in Antibiotic Resistance
Efflux pumps can reduce the intracellular drug 
concentration and block the antibiotics in reaching 
their targets in the microbial cell; hence, bacteria only 
experience subinhibitory levels of antibiotics, which 
could trigger other resistance mechanisms such as change 
in the structure of antibiotics targets due to mutation 
or enzymatic deactivation of antibiotics.19 Efflux pumps 
work in 3 levels of resistance. First, they make the 
bacteria intrinsically resistant by expression in the basal 
level. Second, overexpression of pumps causes acquired 
resistance of mutant strains. Third, in strains that grow 
under stress, temporary overexpression of pumps would 
cause resistance.20,21
RND efflux pumps are crucial in intrinsic and acquired 
resistance in P. aeruginosa. Twelve pump-encoding operons 
have been discovered in the genome of this bacterium.22,23 
These pumps are genetically and structurally similar; 
however, they are different in their substrate specificity 
and regulation.24 Efflux pumps in P. aeruginosa contribute 
to reduced susceptibility toward most antibiotics and 
antibacterial agents.25 The majorly studied pump of this 
bacterium is MexAB-OprM, which constitutes the widest 
spectrum of substrates among all bacterial effluxes like 
quinolones, tetracycline, chloramphenicol, trimethoprim, 
beta-lactam, beta-lactamase inhibitors, macrolides, 
azithromycin, colistin, detergents, and dyes. Other 
pumps involved in drug resistance are OprJ: quinolones 
and erythromycin, MexEF-OprN: chloramphenicol 
and quinolones, and Mex XY: quinolones and 
erythromycin.26
Studies on the efflux pumps of P. aeruginosa have 
not proven the exact role of these pumps in biofilm 
resistance; however, the expression of these pumps 
in biofilms is heterogeneous and cells located in the 
substratum reveal maximum levels of expression. Biofilm 
populations demonstrate several expressions due to 
their specific physiochemical conditions.27 Additionally, 
researchers indicate that MexAB-OprM and MexCD-
OprJ are essential for biofilm formation in the presence 
of antibiotics such as azithromycin, ciprofloxacin, 
colistin, and aminoglycosides.19 MexCD-OprJ is crucial 
in the resistance of azithromycin and MexAB-OprM 
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is responsible for colistin resistance. Furthermore, 
planktonic cells of P. aeruginosa reveal overexpression of 
MexEF-OprN in hypoxic conditions.27 Recently, PA1874–
PA1877 is reported as a new efflux pump system involved 
in biofilm resistance. The expression level of PA1874 was 
10-fold higher in biofilm formation than in planktonic 
cells, and deletion of this operon leads to changes in the 
biofilm susceptibility pattern to tobramycin, whereas 
its overexpression leads to decreased susceptibility of 
aminoglycosides and fluoroquinolones in the planktonic 
cells.28
Stewart et al, in 2 studies, demonstrated that efflux 
pumps have no effect on the biofilm resistance in P. 
aeruginosa; these studies, unlike others, reported that 
efflux pumps are responsible for antibiotic resistance only 
in the planktonic cells and their protection role in biofilm 
presumably depends on the physiological condition of the 
biofilm or the presence of specific subpopulations that 
take advantage of efflux expression. Moreover, regulatory 
effects of the efflux pumps on biofilm could be strain and 
condition dependent.29,30
In general, little data is available on the regulation of efflux 
pump expression in biofilms; however, Liao et al reported 
that presumably there exists a relation between BrlR (Mer 
type transcriptional factor) and efflux pump expression 
in biofilms. BrlR responds to the concentration of the 
second messenger c-diGMP and changes the expression 
of several genes. In addition, Liao et al demonstrated that 
BrlR is required for the maximum expression of MexAB-
OprM and MexEF-OprN in biofilms of P. aeruginosa. 
BrlR binds to the operons of MexAB-OprM and MexEF-
OprN and directly regulates their expression.31
Studies regarding the resistance process of antibiotic 
therapy against biofilm formation in burn wound 
infections report that inactive cells in the deeper layers 
of biofilms (persister cells) are resistant to a wide range of 
antibiotics, which target several biological processes like 
protein synthesis, cell division, and cell wall formation. 
Studies indicate that efflux pumps are responsible 
for the “active defense” of persisters.32 Colistin from 
polymixins family, which is an effective antibiotic against 
a majority of the Gram-negative bacteria and acts as the 
last line defense in resistant infections like P. aeruginosa, 
Acinetobacter baumanii, Klebsiella pneumonia, and 
Enterobacteriaceae, reveals its efficiency on the persister 
cells in the deep layers of biofilms. The gene of resistance 
for colistin was initially reported in 2016,33 and a study 
reported that MexAB-oprM pumps possess an active 
role in causing resistance in the deep layers of biofilms.34 
Moreover, this pump in cooperation with MexCD-OprJ 
is responsible for macrolides and azithromycin resistance 
against biofilms.
In general, utilizing the antiefflux pumps such as PABN, 
carbonyl cyanide, and chloropropharin, decrease the 
biofilm formation; however, the molecular mechanism is 
elusive.35
The Role of Efflux Pumps in Pathogenicity
Efflux pumps were initially presented as a resistance 
mechanism in E. coli in 1980.36 It is assumed that 
considering the conserved genes of these systems 
among different strains and their variety of substrates,17 
other than their antibiotic resistance, these may also 
be physiologically essential.18 A study reveals that 
detoxification of intercellular metabolites, pathogenicity 
in plant and animal hosts, homeostasis, and trafficking 
of intracellular signals are certain physiological roles of 
efflux pumps.37
Minimum pathogenicity by efflux pumps is observed 
in MexA mutant strains. In addition, the strains with 
overexpressed pumps are not pathogenic; hence, 
appropriate efflux pump expression is necessary for 
complete pathogenicity.
As aforementioned, efflux pumps are used in intracellular 
signaling. A group of AI can freely pass the bacterial 
membrane; however, several others including PQS 
and OdDHL, due to their hydrophobic nature, must 
be secreted through pumps or membrane vesicules.34 
Expression of MexAB-OprM is not controlled by QS; 
however, studies report that these efflux pumps specify 
the LasR-signal binding by exerting 3oxoCnHSL and do 
not allow the signals of other species in mixed cultures 
to transfer the inappropriate message. Additionally, this 
mechanism may act as a bacterial defense system during 
the utilization of QS inhibitors.38,39
OdDHL is a MexAB-OprM substrate40 and mutants of this 
pump are unable to transport this AI; hence, it results in 
decreased expression of Las regulated virulence factors.41 
MexEF-OprN and MexGHI play an indirect role in QS 
by secreting anthranilate, which is a toxic metabolite 
and a PQS precursor.42 C4-homoserine lactone (C4HSL) 
overexpresses MexAB-OprM. Due to the interaction 
between QS systems, mutation in any of these systems 
would result in less pathogenicity and QS.17
Alternatively, several strains isolated from clinics and 
environment are QS mutants. Hence, the inability of 
the bacteria in QS might be advantageous. These strains 
are generally signal blind, which indicates that they can 
produce AI but cannot respond to it. This might be a result 
of the energy consumption. Signal production would 
utilize 0.01% of the cell energy, whereas signal response 
uses 5% of the cell energy.43 This ability of the cell to 
produce and respond to the signal and to decide whether 
to respond in a particular situation is due to efflux. Efflux 
pump blocks the QS response by increasing the secretion 
of AI or its precursors and enables the bacteria to quickly 
adapt.
The General Relationship Between Efflux Pump and 
QS
1- Overexpression of MexAB-OprM results in increased 
secretion of antibiotics and OdDHL, which increases 
the resistance and decreases the expression of the 
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virulence factors controlled by QS.38,44
2- Expression of MexAB-OprM is induced by C4HSL, 
which results in more antibiotic resistance and 
OdDHL-LasR binding specificity and additional 
control of the gene expression regulated by QS.45,39
3- Lack of MexAB-OprM pump results in the 
accumulation of OdDHL in the cell and limits cell-
cell communication.38
4- The overexpression of MexEF-OprN and production 
of virulence factors controlled by Las or Rhl are 
interlinked.24
Antimicrobial Photodynamic Therapy
Due to the increasing level of drug resistance, finding new 
therapeutic approaches and alternatives or supplementary 
drugs besides antibiotics remains the core priority of 
scientists worldwide. Photodynamic therapy (PDT is 
widely used for cancer treatment. It is also used for 
benign conditions like age-related macular degeneration 
or other dermatological applications.46,47 Additionally, 
PDT is increasingly used as a therapeutic approach 
for infectious diseases.46 When pathogens are targeted 
in PDT, it is referred to as photodynamic inactivation 
(PDI) or antimicrobial PDT (aPDT). Initially, during the 
commencement of the 20th century, the potential of PDT 
as an antimicrobial therapy was revealed when Moan and 
Peng studied the efficiency of acridine orange in killing 
paramecia in the presence of light.48 During aPDT, the 
cellular structures and biomolecules are destroyed due 
to unspecific reactions. A nontoxic dye is used in aPDT 
as photosensitizer (PS) that acts as photoactive drugs, 
collectively with visible light on the appropriate wavelength 
to excite the PS. The excited PS can produce reactive 
oxygen species (ROS) such as hydroxyl radical and singlet 
oxygen that are responsible for killing the cell by energy/
electrons transfer to the ground state in the presence of 
molecular oxygen.49 These excited oxygen molecules are 
unstable; thus, they lose their energy by transpiration of 
light (fluorescence) or heat production to form a structure 
known as triplet state that lasts for microseconds, which 
in comparison to nanoseconds for the excited singlet, is 
more stable. In type II photochemical reaction, the energy 
transfer reaction eventually forms a singlet oxygen (1O2).
50 
This ROS is produced inside or outside the bacterial cell 
and can cause bacterial cell death either by damaging 
the cell membrane or deoxyribonucleic acid (DNA). 
The light wavelength could differ with due attention to 
the PS structure. As different families of PSs are used for 
different bacteria, several infections are studied to find 
the appropriate PS for each pathogen. The perfect PS 
structure for aPDT would differ from the anticancer PSs; 
in antimicrobial aPDT, we prefer PSs with cationic charges, 
in particular; to target the Gram-negative bacteria the 
more charge of PS is desirable.50 In 1990, studies reported 
cationic PS like porphyrins,51 phenothiazinium,52 and 
phthalocyanines,53 which stimulated quick and immense 
light killing of gram-negative bacteria such as E. coli and 
P. aeruginosa on top of PDT of gram-positive bacteria 
and fungi (For a detailed review of the photosensitizer 
families, refer to reference 49).
Although cancer therapy was the chief target for PDT 
from 1970 to 2010, recently, with the alarming rate of 
drug-resistant pathogens, aPDT is considered as the 
antibacterial approach.50 Few advantages of aPDT are: (1) 
it is board-spectrum and is effective for a wide range of 
targets such as both Gram-positive and Gram-negative 
bacteria, fungi, protozoa and even inactive viruses. (2) 
There is a poor possibility of developing photoresistant 
species even after multiple PDTs. (3) We could target 
aPDT with selectivity for pathogens to avoid side effect 
on host tissues. (4) Less chance of inducing mutagenic 
effect exists. (5) aPDT is faster than antibiotic therapy, 
requiring only a few minutes to kill the pathogens, which 
is in contrast to antibiotics that may require days or even 
weeks to achieve maximum effects. (6) Studies reported 
that aPDT can be effective in biofilm infections where 
antibiotics are generally ineffective. (7) aPDT is affordable 
and inexpensive.54
Pseudomonas aeruginosa uses enzymes like catalase 
and superoxide dismutase or its green-blue pigment 
(pyocyanin), which are partly controlled by QS, to evade 
the harmful effect of aPDT. Furthermore, efflux pumps 
can decline the effect of aPDT by extruding PS. In 2005 
and 2008, 2 different studies initially reported that PS 
from phenothiazinium family like toluidine blue, which is 
widely used in aPDT, is a substrate for multidrug-resistant 
pumps in P. aeruginosa, Staphylococcus aureus, and E. 
coli.55,56 Another study on biofilms of Enterococcus faecalis 
indicated that the presence of efflux pumps inhibitors can 
increase the efficiency of aPDT with methylene blue.57
5-aminolevulinic acid (5-ALA) is a precursor of 
porphyrin that is produced in the bacterial cell during 
heme synthesis and its intracellular accumulation can 
result in light sensitivity and ROS production; recently, 
ALA and protoporphyrin are used as PSs in aPDT for 
superficial infections. In 2014, a survey on E. coli reported 
that use of efflux pumps inhibitors, collectively with an 
iron-chelating agent, could significantly increase the 
efficacy of protoporphyrin-IX-mediated aPDT.58 Another 
study on the virulence factor expression in S. aureus 59 
demonstrated that oxidative damage caused by aPDT 
can alter the expression level of certain proteins such as 
functional proteins involved in cell division, metabolic 
activities, oxidative stress response, and sugar uptakes. 
A study on the effect of sub-lethal PDT (sPDT) with 
methylene-blue on virulence factors of A. baumanii 
indicates that sPDT increases the accumulation of efflux 
pumps and also decreases the expression of specific 
genes such as epsA (membrane protein responsible for 
polysaccharides extrusion), csuE (adhesion involved in 
biofilm formation), abaI (AHL-producing signal, essential 
for QS and biofilm development).60 Alternatively, a recent 
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study on V. harvey reported that low dose of laser not only 
is bactericidal but also has a positive effect on growth and 
increases QS.61
Conclusion and Future Directions
In conclusion, P. aeruginosa is the chief bacteria involved 
in a life-threatening infection in burn patient wound; its 
ability to form biofilms that can adhere to both biotic and 
abiotic surfaces make this bacterium resistant to almost 
all the antibiotics and therapeutic approaches. Therefore, 
it is essential to find novel efficient methods to tackle drug 
resistance in P. aeruginosa’s biofilm-related infections.62-64 
QS and efflux pumps are the major mechanisms for 
pathogenicity and resistance of P. aeruginosa. These 
systems, in addition to their response to the extracellular 
environment, interact together and affect each other’s 
functions. aPDT as an adjuvant method, besides 
antibiotics, received undivided attention during the last 
decade.
aPDT, in addition to killing the major pathogenic 
population, can alter the expression pattern in a limited 
population. This phenomenon could either upset the 
balance between systems and decrease the bacterial 
pathogenicity or increase the bacterial pathogenicity and 
make treatment even more difficult. Based on the review of 
literature referred in this study, we studied the importance 
of P. aeruginosa in infections and intercellular connections 
of QS and efflux pumps in P. aeruginosa and their effect 
on resistance and their reaction to aPDT. Improvement of 
this therapeutic approach and its applications in clinical 
cases of burn wounds requires specific cellular research on 
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